Barry D. Liboiron

1.4k total citations
22 papers, 1.1k citations indexed

About

Barry D. Liboiron is a scholar working on Inorganic Chemistry, Biomaterials and Molecular Biology. According to data from OpenAlex, Barry D. Liboiron has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Inorganic Chemistry, 9 papers in Biomaterials and 8 papers in Molecular Biology. Recurrent topics in Barry D. Liboiron's work include Vanadium and Halogenation Chemistry (9 papers), Nanoparticle-Based Drug Delivery (9 papers) and Metal-Catalyzed Oxygenation Mechanisms (5 papers). Barry D. Liboiron is often cited by papers focused on Vanadium and Halogenation Chemistry (9 papers), Nanoparticle-Based Drug Delivery (9 papers) and Metal-Catalyzed Oxygenation Mechanisms (5 papers). Barry D. Liboiron collaborates with scholars based in United States, Canada and Russia. Barry D. Liboiron's co-authors include Chris Orvig, Lawrence D. Mayer, Katherine H. Thompson, John H. McNeill, Violet G. Yuen, Troy O. Harasym, Sergei A. Dikanov, Edmond Lam, Nicolas Aebischer and Graeme R. Hanson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

In The Last Decade

Barry D. Liboiron

21 papers receiving 1.1k citations

Peers

Barry D. Liboiron

BIOMA

ONCOL

HEMAT

Arthur D. Tinoco Puerto Rico

Subrata Shaw United States

Kathryn L. Haas United States

Tiziana Pivetta Italy

Milan Jakubek Czechia

Amir Sh. Saljooghi Iran

J.L. Pierre France

Mamata Singh India

Xiu‐Ying Qin China

Arthur D. Tinoco Puerto Rico

Barry D. Liboiron

207 ×0.4

282 ×0.7

81 ×0.4

BIOMA

411 ×2.1

ONCOL

87 ×0.6

HEMAT

Citations per year, relative to Barry D. Liboiron Barry D. Liboiron (= 1×) peers Arthur D. Tinoco

Countries citing papers authored by Barry D. Liboiron

Since Specialization

Citations

This map shows the geographic impact of Barry D. Liboiron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry D. Liboiron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry D. Liboiron more than expected).

Fields of papers citing papers by Barry D. Liboiron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry D. Liboiron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry D. Liboiron. The network helps show where Barry D. Liboiron may publish in the future.

Co-authorship network of co-authors of Barry D. Liboiron

This figure shows the co-authorship network connecting the top 25 collaborators of Barry D. Liboiron. A scholar is included among the top collaborators of Barry D. Liboiron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry D. Liboiron. Barry D. Liboiron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Tara L., Laura F. Newell, Robert K. Stuart, et al.. (2019). A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias. Cancer Chemotherapy and Pharmacology. 84(1). 163–173. 13 indexed citations

Mayer, Lawrence D., et al.. (2015). Abstract B34: Coordinated delivery of anticancer drug combinations incorporating molecularly targeted agents provides markedly increased plasma drug exposure, decreased toxicity and increased efficacy in preclinical tumor models. Molecular Cancer Therapeutics. 14(12_Supplement_2). B34–B34. 1 indexed citations

Liboiron, Barry D. & Lawrence D. Mayer. (2014). Nanoscale Particulate Systems for Multidrug Delivery: Towards Improved Combination Chemotherapy. Therapeutic Delivery. 5(2). 149–171. 46 indexed citations

Stern, Stęphan T., Peng Zou, Sherwin Xie, et al.. (2013). Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretion. Journal of Controlled Release. 172(2). 558–567. 8 indexed citations

Dikanov, Sergei A., Barry D. Liboiron, & Chris Orvig. (2013). VO²⁺–hydroxyapatite complexes as models for vanadyl coordination to phosphate in bone. Molecular Physics. 111(18-19). 2967–2979. 12 indexed citations

Feldman, Eric J., Jonathan E. Kolitz, J M Trang, et al.. (2012). Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia. Leukemia Research. 36(10). 1283–1289. 85 indexed citations

Lim, Wah-Seng, Paul Tardi, Nancy Dos Santos, et al.. (2010). Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts. Leukemia Research. 34(9). 1214–1223. 118 indexed citations

Dicko, Awa, Sungjong Kwak, April A. Frazier, Lawrence D. Mayer, & Barry D. Liboiron. (2010). Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin. International Journal of Pharmaceutics. 391(1-2). 248–259. 67 indexed citations

Harasym, Troy O., Barry D. Liboiron, & Lawrence D. Mayer. (2009). Drug Ratio-Dependent Antagonism: A New Category of Multidrug Resistance and Strategies for Its Circumvention. Methods in molecular biology. 596. 291–323. 28 indexed citations

10.

Liboiron, Barry D.. (2009). Biologically relevant physical studies of insulin-enhancing vanadium complexes. Open Collections. 1 indexed citations

11.

Ansell, Steven M., Sharon A. Johnstone, Paul Tardi, et al.. (2008). Development of highly efficacious hydrophobic paclitaxel prodrugs delivered in nanoparticles for fixed-ratio drug combination applications. Cancer Research. 68. 5734–5734. 3 indexed citations

12.

Dicko, Awa, April A. Frazier, Barry D. Liboiron, et al.. (2008). Intra and Inter-Molecular Interactions Dictate the Aggregation State of Irinotecan Co-Encapsulated with Floxuridine Inside Liposomes. Pharmaceutical Research. 25(7). 1702–1713. 15 indexed citations

13.

Augustine, Anthony J., Ritimukta Sarangi, Satoshi Fujii, et al.. (2008). Spectroscopic Studies of Perturbed T1 Cu Sites in the Multicopper Oxidases Saccharomyces cerevisiae Fet3p and Rhus vernicifera Laccase: Allosteric Coupling between the T1 and Trinuclear Cu Sites. Biochemistry. 47(7). 2036–2045. 50 indexed citations

14.

Yoon, Jungjoo, Barry D. Liboiron, Ritimukta Sarangi, et al.. (2007). The two oxidized forms of the trinuclear Cu cluster in the multicopper oxidases and mechanism for the decay of the native intermediate. Proceedings of the National Academy of Sciences. 104(34). 13609–13614. 74 indexed citations

15.

Liboiron, Barry D., Katherine H. Thompson, Graeme R. Hanson, et al.. (2005). New Insights into the Interactions of Serum Proteins with Bis(maltolato)oxovanadium(IV): Transport and Biotransformation of Insulin-Enhancing Vanadium Pharmaceuticals. Journal of the American Chemical Society. 127(14). 5104–5115. 138 indexed citations

16.

Dikanov, Sergei A., Barry D. Liboiron, Katherine H. Thompson, et al.. (2003). One and Two Dimensional Pulsed Electron Paramagnetic Resonance Studies of in vivo Vanadyl Coordination in Rat Kidney. Bioinorganic Chemistry and Applications. 1(1). 69–83. 2 indexed citations

17.

Orvig, Chris, Katherine H. Thompson, Barry D. Liboiron, John H. McNeill, & Violet G. Yuen. (2003). Biolocalization and in vivo coordination chemistry of vanadium pharmaceuticals. Journal of Inorganic Biochemistry. 96(1). 14–14. 10 indexed citations

18.

Thompson, Katherine H., Barry D. Liboiron, Sun Yan, et al.. (2003). Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential. JBIC Journal of Biological Inorganic Chemistry. 8(1). 66–74. 156 indexed citations

19.

Dikanov, Sergei A., Barry D. Liboiron, & Chris Orvig. (2002). Two-Dimensional (2D) Pulsed Electron Paramagnetic Resonance Study of VO²⁺−Triphosphate Interactions: Evidence for Tridentate Triphosphate Coordination, and Relevance To Bone Uptake and Insulin Enhancement by Vanadium Pharmaceuticals. Journal of the American Chemical Society. 124(12). 2969–2978. 59 indexed citations

20.

Dikanov, Sergei A., Barry D. Liboiron, Katherine H. Thompson, et al.. (1999). In Vivo Electron Spin−Echo Envelope Modulation (ESEEM) Spectroscopy: First Observation of Vanadyl Coordination to Phosphate in Bone. Journal of the American Chemical Society. 121(47). 11004–11005. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact